Clemence Lacroix

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Monitoring of new psychoactive substances in France: update of addictovigilance data.

Monitoring of new psychoactive substances in France: update of addictovigilance data.

Journal: European journal of public health

Published: June 16, 2026

Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program.

Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program.

Journal: Fundamental & clinical pharmacology

Published: July 01, 2025

Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019-2023).

Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019-2023).

Journal: Fundamental & clinical pharmacology

Published: June 04, 2025

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment.

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment.

Journal: British journal of clinical pharmacology

Published: January 06, 2025

Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.

Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.

Journal: CNS drugs

Published: August 30, 2024

Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program.

Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program.

Journal: Therapie

Published: July 02, 2024

Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents.

Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents.

Journal: British journal of clinical pharmacology

Published: June 14, 2024

Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.

Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.

Journal: CNS drugs

Published: May 02, 2024

Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.

Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.

Journal: Fundamental & clinical pharmacology

Published: September 06, 2023

Antibiotic-induced neurological adverse drug reactions.

Antibiotic-induced neurological adverse drug reactions.

Journal: Therapie

Published: July 11, 2023

Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020

Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020

Journal: Therapie

Published: April 21, 2023

Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox.

Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox.

Journal: Therapie

Published: March 29, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026